Results 31 to 40 of about 5,200 (157)

Changes in cardiac sympathetic nerve activity on 123I‐metaiodobenzylguanidine scintigraphy after MitraClip therapy

open access: yesESC Heart Failure, 2021
Aims In patients with heart failure, over‐activation of the cardiac sympathetic nerve (CSN) function is associated with severity of heart failure and worse outcome.
Keisuke Fukuda   +6 more
doaj   +1 more source

Extent and determinants of left ventricular reverse remodeling in patients with secondary mitral regurgitation undergoing MitraClip implantation

open access: yesInternational Journal of Cardiology: Heart & Vasculature, 2021
Background: In secondary MR, data on left ventricular (LV) remodeling after MitraClip procedure are rare, even this information may impact patient selection.
Maximilian Spieker   +7 more
doaj   +1 more source

Immediate single-leaflet device detachment in a patient with marfan syndrome treated with bail-out edge-to-edge mitral valve repair

open access: yesHeart Views, 2022
Mitral transcatheter edge-to-edge repair (MTEER) is the first transcatheter technique for mitral valve repair (MVR) in patients with severe mitral regurgitation (MR) who are considered at high risk for surgical intervention.
Khaled Al Khodari   +3 more
doaj   +1 more source

Comparison of costs associated with transcatheter mitral valve repair: PASCAL vs MitraClip in a real-world setting

open access: yesBMC Health Services Research, 2023
Aims We aimed to conduct a clinical process cost analysis to evaluate all upcoming costs of mitral valve transcatheter edge-to-edge repair (M-TEER) treatment using the MitraClip and the PASCAL repair system. Methods First, we prospectively enrolled 107 M-
Jean Marc Haurand   +6 more
doaj   +1 more source

Transesophageal Echocardiography for Mitral Valve Transcatheter Edge-to-Edge Repair

open access: yesJournal of the Indian Academy of Echocardiography & Cardiovascular Imaging, 2022
Transcatheter edge-to-edge repair (TEER) has emerged as a viable treatment option for patients with degenerative or functional severe mitral regurgitation (MR) who are at high risk for mitral valve surgery but have mitral valve anatomy suitable for TEER.
Nitin J Burkule, Manish Bansal
doaj   +1 more source

Contemporary Management of Secondary Mitral Regurgitation

open access: yesEuropean Cardiology Review, 2020
Secondary mitral regurgitation (SMR) is a common occurrence in patients with heart failure with reduced ejection fraction. Moderate-severe or severe SMR is associated with increased mortality and hospitalisations from heart failure.
Kashish Goel   +2 more
doaj   +1 more source

Atrial Fibrillation Predicts Long-Term Outcome after Transcatheter Edge-to-Edge Mitral Valve Repair by MitraClip Implantation

open access: yesBiomolecules, 2018
Background: Atrial fibrillation is common in patients with mitral regurgitation (MR) and has a negative impact on the clinical outcome of patients with valvular heart disease.
Mirjam Keßler   +6 more
doaj   +1 more source

Impact of post-procedural length of stay on short-term outcomes and readmissions after TAVR and MitraClip

open access: yesAmerican Heart Journal Plus, 2022
Background: Post-procedural hospital length of stay (P-LOS) is an important determinant of cost-related outcomes. In the present study, we aimed to assess the impact of P-LOS on short-term outcomes after transcatheter aortic valve replacement (TAVR) and ...
Omar M. Abdelfattah   +11 more
doaj   +1 more source

An unexpected complication of the MitraClip device: one of the arms gets stuck inside the guide catheter in the left atrium

open access: yesTürk Kardiyoloji Derneği Arşivi, 2015
Percutaneous edge-to-edge mitral valve repair using the MitraClip (Abbot Vascular, USA) system is a promising technique for mitral regurgitation treatment in select high-risk surgical patients.
Cüneyt Toprak   +4 more
doaj   +1 more source

Complications following transcatheter edge-to-edge mitral valve repair: Personal experience and review of the literature

open access: yesCardiology Journal, 2023
Mitral valve dysfunction affects around 2% of the population and its incidence is still increasing, making it the second most common valvular heart disease, after aortic stenosis.
Dominik Maj   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy